VP Venture Partners, based in Zürich, is a venture capital fund investing in later-stage health tech companies, specifically Series B. Their focus includes medical devices, diagnostics, digital health, and enabling technologies that address unmet medical needs. Notable investment includes Hemotune. The firm works closely with entrepreneurs to support their portfolio companies' success.
